Business

CNBC’s Jim Cramer said Monday that the old “sell in May and go away” investment adage does not fit in 2019. “More like ‘sell in May and miss the miraculous Fed-induced rally,’ the best move of the year,” the “Mad Money” host said. “You shouldn’t make financial decisions based on a rhyming couplet. … That’s
0 Comments
Sundar Pichai, chief executive officer of Google, is sworn in during a House Judiciary Committee hearing in Washington, D.C., U.S., on Tuesday, Dec. 11, 2018. Andrew Harrer | Bloomberg | Getty Images As the biggest U.S. technology companies face increasing scrutiny from regulators related to privacy practices and market control, they’re spending a lot more
0 Comments
CNBC’s Jim Cramer on Friday ranked what he thinks are the top video subscription services. The list includes established names, such as Netflix, and looming entrants, such as Disney, to the space. “With so many media companies launching their own subscription streaming services, we need to start thinking about winners and losers here,” the “Mad
0 Comments
CNBC’s Jim Cramer on Friday applauded the quarterly results that Beyond Meat and Zoom Video — two stocks he has been skeptical about — posted Thursday as “things of beauty.” The newly-public companies saw their stocks rally by double-digits after beating Wall Street expectations in their first earnings reports since their recent IPOs. Zoom spiked
0 Comments
CNBC’s Jim Cramer, when asked about Continental Resources, told a viewer that he has turned sour on fossil fuel stocks. “I don’t like the fossil fuel stocks. I don’t like the ones that don’t have dividends, even the ones with dividends aren’t doing that well,” the “Mad Money” host said. “I’m taking a hard pass.”
0 Comments
Former UN Secretary General Ban Ki-Moon. Thomas Trutschel | Photothek | Getty Images A lack of political will is holding the world back from achieving international climate goals, Ban Ki-moon, the former United Nations secretary general, said Thursday. Ban said he is “deeply concerned” by the 2017 decision of President Donald Trump’s administration to pull
0 Comments
HP Acthar made by Mallinckrodt Pharmaceuticals is an anti-inflamatory medicine used by multiple sclerosis patients. Source: Mallinckrodt Pharmaceuticals Pharmaceutical company Mallinckrodt said Wednesday it reached a tentative deal with the U.S. Justice Department to settle a drug bribery probe into Questcor Pharmaceuticals, which it acquired in 2014.  This story is developing. Check back for updates. 
0 Comments